Marshall Wace
EGRX

Marshall Wace’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Marshall Wace’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-223,353
Closed -$833K – 3132
2024
Q3 		$833K Buy
223,353
+27,878
+14% +$133K ﹤0.01% 1724
2024
Q2 		$1.09M Sell
195,475
-61,994
-24% -$270K ﹤0.01% 1646
2024
Q1 		$1.35M Buy
257,469
+113,643
+79% +$624K ﹤0.01% 1531
2023
Q4 		$752K Buy
+143,826
New +$1.42M ﹤0.01% 1576
2023
Q2 		– Sell
-65,967
Closed -$1.87M – 3094
2023
Q1 		$1.87M Buy
65,967
+50,691
+332% +$1.5M ﹤0.01% 1492
2022
Q4 		$447K Buy
+15,276
New +$486K ﹤0.01% 2417
2021
Q2 		– Sell
-23,449
Closed -$979K – 3199
2021
Q1 		$979K Buy
+23,449
New +$1.09M ﹤0.01% 1671
2019
Q4 		– Sell
-51,590
Closed -$2.92M – 2151
2019
Q3 		$2.92M Buy
51,590
+16,040
+45% +$902K 0.02% 653
2019
Q2 		$1.98M Sell
35,550
-14,638
-29% -$763K 0.02% 768
2019
Q1 		$2.53M Sell
50,188
-61,276
-55% -$2.73M 0.02% 667
2018
Q4 		$4.49M Buy
+111,464
New +$5.74M 0.05% 478
2018
Q2 		– Sell
-4,300
Closed -$227K – 872
2018
Q1 		$227K Buy
+4,300
New +$250K 0.01% 505
2015
Q3 		– Sell
-47,509
Closed -$3.84M – 1088
2015
Q2 		$3.84M Buy
+47,509
New +$3.09M 0.05% 337

Other funds holding EGRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Marshall Wace's EGRX Position: Q4 2024 in Review

Marshall Wace sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2024, closing a stake of 223,353 shares — an estimated $833K sold.

Marshall Wace first reported a position in EGRX in Q2 2015 and held it in 13 quarters. The position peaked at $4.49M in Q4 2018. 9 funds tracked by Wall St. Rank hold EGRX as of Q4 2024.

  • Marshall Wace reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
  • Marshall Wace sold 223,353 Eagle Pharmaceuticals, Inc. shares in Q4 2024, an estimated $833K.
  • Marshall Wace first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 13 quarters.
  • Marshall Wace's Eagle Pharmaceuticals, Inc. position peaked at $4.49M in Q4 2018.
  • 9 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2024.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.